Trial intelligence / Profile preview

Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgery

NCT06780202Phase 2Recruiting

Sponsor
Emory University
Start
Jan 2025
Primary completion
Jun 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone in foot disorders, ankle injuries and disorders, Achilles tendon injury, sponsored by Emory University. Started Jan 2025; status: recruiting.

02

Drugs

methylprednisolone
03

Conditions

foot disordersankle injuries and disordersAchilles tendon injury

Beyond the preview

Go deeper on NCT06780202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06780202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call